These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1862735

  • 1. Validation criteria for panic disorder as a nosological entity.
    Rosenberg R, Ottosson JO, Bech P, Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand Suppl; 1991; 365():7-17. PubMed ID: 1862735
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 8. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 9. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 10. Effect of alprazolam on depression in panic disorder.
    Melvin JA, Lydiard RB, Crowe CM, Laraia MT, Fossey MD, Ballenger JC.
    J Clin Psychopharmacol; 1991 Apr; 11(2):145-6. PubMed ID: 2056142
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 Apr; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The sequence of improvement of the symptoms encountered in patients with panic disorder.
    Deltito JA, Argyle N, Buller R, Nutzinger D, Ottosson JO, Brandon S, Mellergard M, Shera D.
    Compr Psychiatry; 1991 Apr; 32(2):120-9. PubMed ID: 2022110
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dexamethasone suppression test in patients with panic disorder and secondary depression.
    Bueno JA, Sabanes F, Gascon J, Gasto C, Salamero M.
    Arch Gen Psychiatry; 1984 Jul; 41(7):723-4. PubMed ID: 6732433
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Jul; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.